Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

INTRODUCTION: Complex underlying risk functions associated with immuno-oncology treatments have led to exploration of different methods (parametric survival, spline, landmark, and cure-fraction models) to estimate long-term survival outcomes. The objective of this study was to examine differences in...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Adv Ther
Egile Nagusiak: Lanitis, Tereza, Proskorovsky, Irina, Ambavane, Apoorva, Hunger, Matthias, Zheng, Ying, Bharmal, Murtuza, Phatak, Hemant
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Healthcare 2019
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822847/
https://ncbi.nlm.nih.gov/pubmed/31350728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-019-01034-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak